A medicine that helps lower bad cholesterol

Original Title

Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins.

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

This study tested a new medicine called AMG 145 that helps lower bad cholesterol in people's blood.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

AMG 145 lowered lipoprotein(a) [Lp(a)] by 27% to 50%, a type of cholesterol that most drugs don’t touch.

Lp(a) is genetically driven and resistant to statins—doctors have long said 'there’s nothing we can do' about it. This suggests PCSK9 inhibitors might change that.

Practical Takeaways

If you're on statins but still have high cholesterol, ask your doctor about PCSK9 inhibitors like this one.

medium confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.

63%
Moderate QualityOverall Score

Publication

Journal

Journal of the American College of Cardiology

Year

2012

Authors

C. Dias, A. Shaywitz, S. Wasserman, Brian Smith, Bing Gao, Dina Stolman, C. Crispino, K. Smirnakis, M. Emery, A. Colbert, J. Gibbs, M. Retter, Blaire P. Cooke, Stephen Uy, M. Matson, E. Stein

Open Access
248 citations
Analysis v1